Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients’ lives by researching, developing, and bringing to market new and effective therapies for many serious diseases and disorders. With the commitment of expert leadership and skilled research scientists, ADVR is aggressively working to bring its flagship product, AVR118, to patients. A real blockbuster potential exists for this new type of biopolymer chemistry, which possesses novel immunomodulator ( www.adviral.com )
Advanced Viral Research Corp.
200 Corporate Blvd. South
Yonkers, New York 10701
USA
Tel: (914) 376-7383
Fax: (914) 376-7368